Preprint · OA via OpenAlex

Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease

Karima Ait‐Aissa, Johnathan Ebben, Andrew O. Kadlec, Andreas Beyer

Pharmacological Research · 2016 · ▲ 35 citations

Telomere attrition

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.phrs.2016.07.003
Canonical: link ↗
Fetched: 2026-06-22 MST

Cite this

APA

Ait‐Aissa, K., Ebben, J., Kadlec, A.O., & Beyer, A. (2016). Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease. <em>Pharmacological Research</em>. https://doi.org/10.1016/j.phrs.2016.07.003

Vancouver

Ait‐Aissa K, Ebben J, Kadlec AO, Beyer A. Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease. Pharmacological Research. 2016. doi:10.1016/j.phrs.2016.07.003.

BibTeX

@unpublished{karima2016Friend, title = {Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease}, author = {Karima Ait‐Aissa and Johnathan Ebben and Andrew O. Kadlec and Andreas Beyer}, journal = {Pharmacological Research}, year = {2016}, doi = {10.1016/j.phrs.2016.07.003}, }